Alternative splicing and related RNA binding proteins in human health and disease

Y Tao, Q Zhang, H Wang, X Yang, H Mu - Signal transduction and …, 2024 - nature.com
Alternative splicing (AS) serves as a pivotal mechanism in transcriptional regulation,
engendering transcript diversity, and modifications in protein structure and functionality …

Biomarkers for parkinsonian disorders in CNS-originating EVs: promise and challenges

S Dutta, S Hornung, HB Taha, G Bitan - Acta Neuropathologica, 2023 - Springer
Extracellular vesicles (EVs), including exosomes, microvesicles, and oncosomes, are nano-
sized particles enclosed by a lipid bilayer. EVs are released by virtually all eukaryotic cells …

A review on comparative studies addressing exosome isolation methods from body fluids

TS Martins, M Vaz, AG Henriques - Analytical and Bioanalytical Chemistry, 2023 - Springer
Exosomes emerged as valuable sources of disease biomarkers and new therapeutic tools.
However, extracellular vesicles isolation with exosome-like characteristics from certain …

Biomarkers used in Alzheimer's disease diagnosis, treatment, and prevention

YAR Mahaman, KS Embaye, F Huang, L Li, F Zhu… - Ageing research …, 2022 - Elsevier
Abstract Alzheimer's disease (AD), being the number one in terms of dementia burden, is an
insidious age-related neurodegenerative disease and is presently considered a global …

L1CAM is not associated with extracellular vesicles in human cerebrospinal fluid or plasma

M Norman, D Ter-Ovanesyan, W Trieu, R Lazarovits… - Nature …, 2021 - nature.com
L1CAM is a transmembrane protein expressed on neurons that was presumed to be found
on neuron-derived extracellular vesicles (NDEVs) in human biofluids. We developed a …

L1CAM‐associated extracellular vesicles: A systematic review of nomenclature, sources, separation, and characterization

DE Gomes, KW Witwer - Journal of Extracellular Biology, 2022 - Wiley Online Library
When released into biological fluids like blood or saliva, brain extracellular vesicles (EVs)
might provide a window into otherwise inaccessible tissue, contributing useful biomarkers of …

Hypoxia-induced alternative splicing: the 11th Hallmark of Cancer

AR Farina, L Cappabianca, M Sebastiano… - Journal of Experimental …, 2020 - Springer
Hypoxia-induced alternative splicing is a potent driving force in tumour pathogenesis and
progression. In this review, we update currents concepts of hypoxia-induced alternative …

Single‐extracellular vesicle (EV) analyses validate the use of L1 cell adhesion molecule (L1CAM) as a reliable biomarker of neuron‐derived EVs

CJ Nogueras‐Ortiz, E Eren, P Yao… - Journal of …, 2024 - Wiley Online Library
Isolation of neuron‐derived extracellular vesicles (NDEVs) with L1 Cell Adhesion Molecule
(L1CAM)‐specific antibodies has been widely used to identify blood biomarkers of CNS …

Circular RNAs: novel actors of Wnt signaling pathway in lung cancer progression

M Alimohammadi, Y Gholinezhad, V Mousavi… - EXCLI …, 2023 - pmc.ncbi.nlm.nih.gov
Circular RNAs (CircRNAs) are a class of regulatory RNA transcripts, which are ubiquitously
expressed in eukaryotes. CircRNA dysregulation has been shown to disrupt the interaction …

Molecular mechanisms of non-genetic aberrant peptide production in cancer

D Wernaart, A Fumagalli, R Agami - Oncogene, 2024 - nature.com
The cancer peptidome has long been known to be altered by genetic mutations. However,
more recently, non-genetic polypeptide mutations have also been related to cancer cells …